MedTrace Logo

Prospective Multi-Center Trial for FemBloc Permanent Birth Control

NCT05977751 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 573

Last updated 2026-03-03

No results posted yet for this study

Summary

Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.

Conditions

  • Contraception

Interventions

DEVICE

FemBloc

Treatment for women who desire non-surgical permanent birth control by occlusion of the fallopian tubes.

Sponsors & Collaborators

  • Femasys Inc.

    lead INDUSTRY

Principal Investigators

  • Study Sponsor · Medical Affairs and Clinical Development

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2029-12-31
Completion
2031-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05977751 on ClinicalTrials.gov